Home > Tag Archives: BASE Inhibitors

Tag Archives: BASE Inhibitors

Eli Lilly Teams Up With UK Pharmaceutical Company For New Alzheimer’s Drug

Eli Lilly yesterday announced a partnership with U. K. drug maker AstraZeneca to develop and commercialize a potential new drug for Alzheimer’s.  AstraZeneca will produce the drug, ASD3293, and Lilly will lead the clinical trials.  The drug is one of a class of drugs called BASE inhibitors.   BASE inhibitors inhibit an enzyme, beta-secretase, which is involved in forming the plaques …

Read More »